Lung infection treatment study (AcCREDiT 2)
Part of Infections, Lungs & breathing clinical trials.
This study looks at how well different treatments work for people with lung infections or sudden worsening of chronic lung disease. If you have a respiratory sample available and are about to start an antibiotic, antiviral, antifungal, or steroid, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a suspected acute respiratory infection or a sudden worsening of a chronic lung disease (like COPD or asthma)
- A sample from your lungs is available (either sputum you cough up or a lung wash if you are on a breathing machine in intensive care)
- You are scheduled to receive either an anti-infective drug (like an antibiotic, antiviral, or antifungal) OR a steroid medicine
- You must give informed consent (or have a family member or doctor give permission for you to join)
- You can join again if you have a separate, new breathing problem later
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
This trial compares customized durations of antibiotics to standard durations for treating acute worsening of COPD. It aims to see if stopping antibiotics early when symptoms improve is as effective as the usual fixed course.
This study collects blood samples from people in the ICU with sudden heart or lung problems caused by inflammation. The goal is to learn more about these conditions and improve future treatments.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This study tests new diagnostic tools to help quickly identify what's causing your respiratory infection. You'll provide samples (like nasal swabs) to help researchers understand how these new tests work in real patients.
Hear when a new Chronic Respiratory Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.